Deutsche Bank Ag\ Hookipa Pharma Inc. Transaction History

Deutsche Bank Ag\

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.33 - $2.31 $159,971 - $277,844	-120,279 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.26 - $2.52 $1,562 - $3,124	-1,240 Reduced 1.02%	120,279 $274,000
Q4 2021 Feb 11, 2022	BUY	$2.33 - $5.94 $1,444 - $3,682	620 Added 0.51%	121,519 $283,000
Q3 2021 Nov 04, 2021	SELL	$5.89 - $9.35 $2,114 - $3,356	-359 Reduced 0.3%	120,899 $713,000
Q2 2021 Aug 11, 2021	BUY	$9.16 - $19.51 $1.03 Million - $2.2 Million	112,779 Added 1330.1%	121,258 $1.11 Million
Q1 2021 May 13, 2021	SELL	$10.64 - $14.7 $8,235 - $11,377	-774 Reduced 8.36%	8,479 $114,000
Q4 2020 Feb 16, 2021	BUY	$9.32 - $13.63 $23,244 - $33,993	2,494 Added 36.9%	9,253 $103,000
Q3 2020 Nov 12, 2020	BUY	$8.59 - $11.89 $5,188 - $7,181	604 Added 9.81%	6,759 $64,000
Q2 2020 Aug 13, 2020	BUY	$7.23 - $12.1 $18,732 - $31,351	2,591 Added 72.7%	6,155 $71,000
Q1 2020 May 14, 2020	SELL	$5.9 - $13.8 $944 - $2,208	-160 Reduced 4.3%	3,564 $30,000
Q4 2019 Feb 14, 2020	BUY	$6.51 - $12.23 $20,701 - $38,891	3,180 Added 584.56%	3,724 $44,000
Q3 2019 Nov 14, 2019	SELL	$6.45 - $8.44 $6,649 - $8,701	-1,031 Reduced 65.46%	544 $3,000
Q2 2019 Aug 14, 2019	BUY	$6.16 - $14.15 $9,702 - $22,286	1,575 New	1,575 $9,000

677K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $106M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.